QCG
ASND icon

Quadrant Capital Group’s Ascendis Pharma A/S ASND Stock Holding History

Quadrant Capital Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-372
Closed -$85.1K – 1348
2026
Q1 		$85.1K Hold
372
– – ﹤0.01% 1526
2025
Q4 		$79.3K Hold
372
– – ﹤0.01% 1549
2025
Q3 		$74K Buy
+372
New +$69.4K ﹤0.01% 1548
2025
Q2 		– Sell
-372
Closed -$58K – 1430
2025
Q1 		$58K Sell
372
-21
-5% -$3K ﹤0.01% 1666
2024
Q4 		$54.1K Buy
393
+58
+17% +$7.63K ﹤0.01% 1371
2024
Q3 		$50K Sell
335
-7
-2% -$945 ﹤0.01% 1456
2024
Q2 		$46.6K Buy
342
+11
+3% +$1.5K ﹤0.01% 1445
2024
Q1 		$50K Buy
331
+13
+4% +$1.85K ﹤0.01% 1402
2023
Q4 		$40.1K Buy
318
+151
+90% +$15.1K ﹤0.01% 1508
2023
Q3 		$15.6K Sell
167
-29
-15% -$2.71K ﹤0.01% 1809
2023
Q2 		$17.5K Sell
196
-83
-30% -$7.22K ﹤0.01% 1778
2023
Q1 		$29.9K Sell
279
-71
-20% -$8.12K ﹤0.01% 1494
2022
Q4 		$42.7K Buy
350
+71
+25% +$8.24K ﹤0.01% 1255
2022
Q3 		$29K Buy
279
+104
+59% +$9.86K ﹤0.01% 1336
2022
Q2 		$16K Sell
175
-30
-15% -$2.83K ﹤0.01% 1405
2022
Q1 		$24K Sell
205
-59
-22% -$6.83K ﹤0.01% 1238
2021
Q4 		$36K Buy
264
+51
+24% +$7.59K ﹤0.01% 1041
2021
Q3 		$34K Buy
213
+41
+24% +$5.61K ﹤0.01% 1007
2021
Q2 		$23K Buy
172
+102
+146% +$13.6K ﹤0.01% 1135
2021
Q1 		$9K Buy
70
+26
+59% +$3.95K ﹤0.01% 1525
2020
Q4 		$7K Buy
44
+17
+63% +$2.81K ﹤0.01% 1545
2020
Q3 		$4K Buy
27
+1
+4% +$144 ﹤0.01% 1603
2020
Q2 		$4K Buy
+26
New +$3.57K ﹤0.01% 1715

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Quadrant Capital Group's ASND Position: Q2 2026 in Review

Quadrant Capital Group sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 372 shares — an estimated $85.1K sold.

Quadrant Capital Group first reported a position in ASND in Q2 2020 and held it in 23 quarters. The position peaked at $85.1K in Q1 2026. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Quadrant Capital Group reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 372 Ascendis Pharma A/S shares in Q2 2026, an estimated $85.1K.
  • Quadrant Capital Group first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 23 quarters.
  • Quadrant Capital Group's Ascendis Pharma A/S position peaked at $85.1K in Q1 2026.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.